AGL 24.24 Increased By ▲ 0.77 (3.28%)
AIRLINK 107.70 Increased By ▲ 1.59 (1.5%)
BOP 5.12 Decreased By ▼ -0.05 (-0.97%)
CNERGY 3.63 Decreased By ▼ -0.03 (-0.82%)
DCL 7.32 Decreased By ▼ -0.48 (-6.15%)
DFML 42.10 Decreased By ▼ -2.09 (-4.73%)
DGKC 88.80 Increased By ▲ 0.30 (0.34%)
FCCL 21.75 No Change ▼ 0.00 (0%)
FFBL 41.85 Decreased By ▼ -0.67 (-1.58%)
FFL 8.61 Decreased By ▼ -0.14 (-1.6%)
HUBC 148.75 Increased By ▲ 0.95 (0.64%)
HUMNL 10.14 Decreased By ▼ -0.11 (-1.07%)
KEL 4.28 Decreased By ▼ -0.06 (-1.38%)
KOSM 3.59 Decreased By ▼ -0.20 (-5.28%)
MLCF 36.20 Decreased By ▼ -0.20 (-0.55%)
NBP 47.75 Decreased By ▼ -1.55 (-3.14%)
OGDC 129.10 Decreased By ▼ -1.75 (-1.34%)
PAEL 25.75 Decreased By ▼ -0.20 (-0.77%)
PIBTL 6.00 Decreased By ▼ -0.05 (-0.83%)
PPL 113.65 Decreased By ▼ -0.90 (-0.79%)
PRL 22.30 Decreased By ▼ -0.30 (-1.33%)
PTC 12.10 Decreased By ▼ -0.27 (-2.18%)
SEARL 54.98 Decreased By ▼ -0.72 (-1.29%)
TELE 7.11 Decreased By ▼ -0.14 (-1.93%)
TOMCL 37.11 Increased By ▲ 0.71 (1.95%)
TPLP 7.76 Decreased By ▼ -0.19 (-2.39%)
TREET 15.00 Decreased By ▼ -0.29 (-1.9%)
TRG 55.54 Decreased By ▼ -1.16 (-2.05%)
UNITY 31.20 Decreased By ▼ -0.65 (-2.04%)
WTL 1.15 Decreased By ▼ -0.02 (-1.71%)
BR100 8,248 Decreased By -46.7 (-0.56%)
BR30 25,878 Decreased By -223.8 (-0.86%)
KSE100 78,030 Decreased By -439.8 (-0.56%)
KSE30 25,084 Decreased By -114.2 (-0.45%)
World

Brazil's vaccination plan is assailed as 'incompetent'

  • The Datafolha poll found 50 percent of respondents said they would not take a vaccine made in China, against 47 percent who would.
Published December 14, 2020

RIO DE JANEIRO: President Jair Bolsonaro faced scathing criticism Sunday over his government's plan -- or lack thereof, opponents said -- to vaccinate the population against Covid-19 in Brazil, the country with the second-highest death toll worldwide.

Brazil published its vaccination plan Saturday with notable holes, including a start date and details of how to reach its target of 70 percent of the population.

That prompted a new salvo of criticism of the far-right president, who has persistently defied expert advice on containing the pandemic and recently declared he did not plan to be vaccinated.

"Enough shenanigans with the vaccine!" leading newspaper Folha de Sao Paulo said in a front-page editorial.

"President Jair Bolsonaro's murderous stupidity in the face of the coronavirus pandemic has surpassed all limits."

Rival daily Estado de Sao Paulo condemned the government's "lethal incompetence."

"Faced with the worst health crisis of our era, this government's response will be remembered as disastrous in every sense right up to its vaccination plan," it said.

The plan, which the Supreme Court required the government to present, gives a rough sketch of the target populations and vaccines to be used in Brazil's initial immunization drive.

It envisions four phases targeting sensitive groups, including health workers, the elderly, indigenous Brazilians and teachers, for a total of 51.6 million people, or 24 percent of the population of 212 million.

The plan says the optimal target is to vaccinate more than 70 percent of the population but provides no details on how to reach that figure.

Experts said details on the timeline, logistics and sources of vaccines were also lacking.

Judge orders start date

Supreme Court Justice Ricardo Lewandowski ordered the government to set the start date for the vaccination drive within 48 hours.

"It would be irresponsible to give a specific date because it depends on the registration" at Brazil's regulatory agency, deputy health minister Elcio Franco responded in a video message.

"The federal government is not going to announce anything irresponsibly."

"We never saw any version of this document," said one, epidemiologist Ethel Maciel.

Other experts were bluntly critical of the plan.

"The health ministry is trying to make the Brazilian people and the Supreme Court look like clowns," tweeted microbiologist Natalia Pasternak, a regular critic of the government's response to Covid-19.

She pointed out that the plan counted on 70 million doses of US pharmaceutical firm Pfizer's vaccine, even though their purchase is still being negotiated, and provided no information on how they would be stored at the required -70 degrees Celsius (-94 degrees Fahrenheit).

'New Vaccine Revolt'

Even as the world's long wait for a Covid-19 vaccine reaches the beginning of the end in Britain and elsewhere, the matter is caught up in a messy political battle in Brazil.

Bolsonaro's anti-vaccine stance contrasts with that of Sao Paulo Governor Joao Doria, a top contender to challenge him for the presidency in 2022.

Doria is pushing to start immunizing people on January 25 with Chinese-developed vaccine CoronaVac, which his state is helping test and produce.

Bolsonaro vocally opposes that plan, deriding CoronaVac as "Joao Doria's Chinese vaccine."

The federal vaccination plan does not include CoronaVac.

The row has escalated into what some commentators are calling a "new Vaccine Revolt," in reference to a deadly 1904 uprising against the smallpox vaccine in Rio de Janeiro.

Critics say Bolsonaro's skeptical comments are deterring many Brazilians from getting vaccinated.

Folha published a poll Sunday finding that 22 percent of Brazilians do not plan to be vaccinated against Covid-19, up from nine percent in August.

The Datafolha poll found 50 percent of respondents said they would not take a vaccine made in China, against 47 percent who would.

It also found Bolsonaro's approval rating holding steady despite the pandemic, at 37 percent -- the same as in August, and the best rating of his term.

Bolsonaro, who has downplayed the new coronavirus as a "little flu," said Thursday that "we're at the tail end of the pandemic."

Experts, however, say the country is undergoing a second wave.

After a more than two-month drop, Brazil's curve of average weekly Covid-19 deaths has been rising sharply in recent weeks.

The total death toll in Brazil is now 181,402, second only to the more than 299,000 in the United States.

Comments

Comments are closed.